Apnimed, Inc. Common Stock (APMD) — Working Capital to Net Assets Ratio
Apnimed, Inc. Common Stock (APMD) has a Working Capital to Net Assets ratio of 114.0% as of March 2026. Working capital of $293.61 Million (current assets of $332.00 Million minus current liabilities of $38.39 Million) is measured against net assets of $257.59 Million. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Apnimed, Inc. Common Stock Working Capital to Net Assets (2024–2025)
This chart shows how Apnimed, Inc. Common Stock's Working Capital to Net Assets ratio has evolved across 2 annual periods from 2024 to 2025. As of March 2026, the ratio stands at 114.0%, reflecting working capital of $293.61 Million against net assets of $257.59 Million USD. See APMD defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Apnimed, Inc. Common Stock (2024–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Apnimed, Inc. Common Stock from 2024 to 2025, covering 2 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Apnimed, Inc. Common Stock asset portfolio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 17.7% | $-65.82 Million | $-372.78 Million | $45.05 Million | $110.88 Million | ▲ +30.1 pp |
| 2024 | -12.4% | $30.89 Million | $-248.62 Million | $73.25 Million | $42.36 Million | — |